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ABSTRACT Synthetic cis-regulatory systems consisting
of positively and negatively acting cis-regulatory modules of
the Endo16 gene were combined with the lineage-specific
regulatory element of the SM50 gene associated with a re-
porter and injected into eggs of sea urchins. We show here that
synthetic cis-regulatory systems consisting of the positive
Endo16 regulatory elements linked with the SM50 regulatory
element are expressed spatially exactly as the sum of the
individual endodermal and skeletogenic expression patterns.
In combination, both lineage-specific positive regulatory ele-
ments function autonomously. However, addition of the
Endo16 regulatory module that represses ectopic skeletogenic
expression of Endo16 receptor constructs does not affect
expression driven by the SM50 regulatory elements in the
same skeletogenic cells. The repression function of this ele-
ment is thus dedicated to control of the positive spatial output
of the Endo16 regulatory system.
The question addressed in this paper is whether a predictable
combination of embryonic spatial gene expression patterns can
be generated by combining cis-regulatory elements from di-
verse genes. We generated chimeric cis-regulatory systems by
combining spatial control elements of the sea urchin genes
Endo16 and SM50. These elements individually direct expres-
sion to the endoderm and skeletogenic domains of the embryo,
respectively. When physically linked in single constructs, these
elements were observed to function autonomously and addi-
tively, producing a novel combined spatial pattern of expres-
sion in the embryo.
In recent studies (1–5), we experimentally defined the
cis-regulatory systems of the SM50 and Endo16 genes of
Strongylocentrotus purpuratus. These are expressed, respec-
tively, in the skeletogenic mesenchyme lineages and in the
endoderm of the embryo, in entirely nonoverlapping patterns.
Endo16 encodes a secreted cell surface protein (6). The gene
is transcribed in the vegetal plate of the early embryo and
throughout the archenteron after invagination. Transcription
is turned off in the secondary mesenchyme cells as they
delaminate from the tip of the gut, andEndo16 expression then
disappears from the foregut and the hindgut, so that at the end
of embryogenesis only the midgut expresses the gene (3, 6).
The 2.3-kb cis-regulatory system of Endo16 consists of at least
six modules. Three of the Endo16 modules, G, B, and A (see
Fig. 1) act positively and synergistically to promote expression
in the endodermal lineages of the embryo (5). Each displays a
particular temporal pattern of expression which also causes a
modest ectopic expression in ectoderm lineages surrounding
the vegetal plate, and in skeletogenic lineages, as well as
correct expression in endodermal lineages. The repressive
spatial functions executed by the other three modules, F, E,
andDC, are required to confine expression to the vegetal plate
and its derivatives (5). DC shuts off the gene in the skeleto-
genic mesenchyme, thus setting the lower boundary of expres-
sion, and modules E or F suffice to turn off Endo16 cis-
regulatory activity in the tier of ectoderm cells adjacent to the
endoderm, thus setting the upper boundary. The cis-regulatory
system that controls SM50 gene expression is considerably
simpler. This gene encodes a spicule matrix protein. It is
expressed exclusively in the skeletogenic mesenchyme lin-
eages, and is controlled by an '500-bp upstream sequence
(Fig. 1A) that responds to a few key activators which are
presumably present, or active, only in skeletogenic lineages
throughout embryogenesis (2). There is no evidence for neg-
ative spatial control elements in the SM50 cis-regulatory system.
MATERIALS AND METHODS
Embryo Culture and Microinjection. S. purpuratus embryos
were cultured and injected as described (7, 8). They were
collected at the appropriate stage and processed for chloram-
phenicol acetyltransferase (CAT) measurements or whole
mount in situ hybridization.
Construction of Reporter Gene Constructs. Starting con-
structs. The SM50zCAT construct (construct 1 of Fig. 1B)
described in ref. 2, and the plasmids GBA–BpzCAT and GD-
CBA–BpzCAT described in ref. 5, were used as starting con-
structs (constructs 2 and 5 of Fig. 1B). These plasmids contain
various fragments of regulatory DNA of SM50 or Endo16, a
transcription initiation site, 59-leader sequences, a CAT fusion
gene, a simian virus 40 (SV40) 39-trailer, and a poly(A)
adenylation site. Bp denotes the Endo16 basal promoter (5).
Experimental constructs. For the cloning ofGBA–SM50zCAT
and GDCBA–SM50zCAT (constructs 3 and 7, Fig. 1B),
SM50zCAT was cut with HindIII and PstI. The GBA and
GDCBA fragments were amplified with primers mod1 and
mod2, usingGBA–BpzCAT andGDCBA–BpzCAT as templates,
respectively. The primer sequences, with introduced HindIII
and PstI sites underlined, were as follows: mod1, 59-
GGAAAGCCTTCTTATTCTAATATCCAC-39; and mod2,
59-GGTCTGCAGAACAGTTTAACCCGG-39. PCRs were
carried out by using the conditions described in ref. 9, the
fragments digested with HindIII and PstI, and subcloned into
SM50zCAT. For cloning of DC–SM50zCAT (construct 4, Fig.
1B), the DC fragment of GDCBA–Bp was amplified in a PCR
by using primers DC1 andDC2. Their sequences, with the SphI
and BglII sites underlined, were as follows: DC1, 59-
CGGGCATGCGACTTCGAACTCATTT-39; and DC2, 59-
CGGAGATCTGTATACCAATACCCGTT-39. The PCR
product was digested with SphI and BglII and inserted into
SM50zCAT cut at the same sites. Similarly, the DC fragment
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was inserted into GBA–SM50zCAT at the SphI and BglII sites
to obtain GBA–DC–SM50zCAT (line 8, Fig. 1B). To clone
GBA–DC–BpzCAT (construct 6, Fig. 1B), GBA–DC–
SM50zCAT was digested with BglII, filled in, and cut with SacI,
which releases the SM50 and CAT sequences, and the SmaI–
SacI fragment of BpzCAT (5) was inserted. The BglII–BamHI
fragment of pMAL-p2 (New England Biolabs) was used as a
nonfunctional spacer. This consists of an '900-bp sequence
encoding the bacterial maltose-binding protein. It was inserted
in antisense orientation into the BglII site of SM50zCAT to
yield plasmid 7SM50zCAT (construct 9, Fig. 1B). To create
plasmid GDCBA7SM50zCAT (line 10, Fig. 1B), the same
pMAL-p2 fragment (7) was inserted intoGDCBA–SM50zCAT
using the singleBglII site. Restriction sites and primers used for
cloning are indicated in Fig. 1B. Plasmids were linearized for
microinjection with SacI.
CAT Measurements and Whole Mount in Situ Hybridiza-
tion.CAT enzyme activity was determined as reported (7), and
whole mount in situ hybridizations were carried out according
to the procedure described in ref. 9. Embryos were analyzed
and digitized with a Roche Instruments imaging system using
PRORES software and a Zeiss Axioskop microscope. Repre-
sentative examples were printed on a Nikon CP-300 Printer.
RESULTS
The spatial expression patterns of the experimental constructs
used in this work were assessed by whole mount in situ
hybridization of CAT mRNA. Incorporation of injected re-
porter constructs in sea urchins is mosaic (8, 10, 11), and thus
only a subset of the cells of each territory in which a given
construct is expressed are stained in any individual embryo. In
this study the percentages of experimental embryos displaying
expression of transgenes was 62–82%, as summarized in Table
1. The eggs were injected following fertilization, and the
embryos were assayed at the late gastrula stage.
Combination of Cell-Type-Specific Modules Results in Ex-
pression in Both Territories. G, B, and A, the positive
endoderm-specific modules of theEndo16 gene (see above and
Fig. 1A), were linked to the SM50 regulatory element that is
FIG. 1. Schematic illustration of the modular cis-regulatory regions of the sea urchin genes Endo16 and SM50, and reporter gene constructs
used in this study. VP, vegetal plate; veg1, veg1 tier; PMC, primary mesenchyme cells; MG, midgut; Bp, basal promoter. (A) Modules of the 59
regulatory regions of Endo16 and SM50. Regulatory modules are indicated by differently shaded or hatched boxes. The Endo16 upstream region
consists of six regulatory modules. Module A drives early expression in the vegetal plate, the adjoining skeletogenic mesenchyme and ectoderm
early in development. The negatively acting modules, DC and E or F, repress gene expression in the skeletogenic mesenchyme and the adjacent
veg1 ectoderm, respectively. Thus, E or F set the upper, andDC the lower, boundary of expression. B is sufficient for midgut-specific late expression,
and G helps both A and B in stepping up the amplitude of expression throughout development. In contrast, the SM50 cis-regulatory region is
organized in a single module and drives expression exclusively in the autonomously specified skeletogenic mesenchyme. (B) Schematic diagrams
of reporter gene constructs. DNA fragments of the Endo16 and SM50 cis-regulatory regions contained in the constructs are shown as boxes.
Restriction sites used to clone reporter gene constructs are indicated. Primers are shown as straight arrows, transcription start sites as bent arrows.
Cis-regulatory sequences are drawn to scale, but not the CAT fusion gene or the primers. Vector sequences were omitted. (Bar 5 100 bp.)
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necessary and sufficient to promote specific, high-level expres-
sion in skeletogenic mesenchyme (PMC) cells. At the gastrula
stage when the observations were made these are the primary
or skeletogenic mesenchyme cells. In an initial series of
experiments we obtained the quantitative expression results
expected for the GBA (5) and SM50 (2) regulatory elements
when these are tested separately. The control construct
SM50zCAT, shown diagrammatically in Fig. 1B, carries the
entire cis-regulatory element of the SM50 gene. This construct
is expressed almost exclusively in the skeletogenic mesen-
chyme cells in all specimens scored as stained. An example of
this type of expression pattern, visualized by whole mount in
situ hybridization, is shown in Fig. 2A, and data from embryos
bearing SM50zCAT are given in Table 1. Ectopic gut and
ectoderm expression are very low, equivalent to background
observed with all injected constructs (3.6% and 5.0%, respec-
tively; Table 1). These data are in very good accord with
previous observations (1, 2). The second control plasmid,
GBA–BpzCAT (line 2 of Fig. 1B), is expressed in archenteron
cells in '95% of all stained embryos (Table 1). However,
GBA–BpzCAT generates $10% ectopic expression in both the
ectoderm and the skeletogenic mesenchyme as is shown in
Table 1. These results are again almost the same as reported
earlier (ref. 6; see Table 1). The GBA and SM50 regulatory
sequences were combined in the fusion gene GBA–SM50zCAT
(line 3 of Fig. 1B). Expression of this construct is detected in
both skeletogenic mesenchyme and gut cells in a high per-
centage of all labeled embryos (93% and 72%, respectively;
Table 1). Ectoderm cells are ectopically stained with the same
frequency as observed in embryos expressing GBA–BpzCAT
(Table 1).
The expression pattern generated byGBA–SM50zCAT is the
sum of those generated by the two individual control plasmids
SM50zCAT and GBA–BpzCAT. The percentages of embryos
displaying staining specific to the skeletogenic mesenchyme, or
the gut, respectively, appear slightly higher for the control
constructs SM50zCAT and GBA–BpzCAT than for GBA–
SM50zCAT (between 5 and 20%; compare data in Table 1 for
SM50zCAT expression in the skeletogenic cells and GBA–
BpzCAT expression in archenteron toGBA–SM50zCAT expres-
sion). This apparent difference is due solely to the requirement
of normalizing to the number of total labeled embryos in a
system in which incorporation of exogenous DNA is mosaic.
That is, the total number of embryos seen to be labeled with
the GBA–SM50zCAT construct is higher ('80% versus 65%;
Table 1) because embryos in which either gut or PMCs alone
contain the exogenous DNA both display labeling, while
embryos bearing either SM50zCAT or GBA–BpzCAT display
labeling only if the exogenous DNA happens to be located in
skeletogenic or endoderm lineages, respectively. If the frac-
tions of embryos in the GBA–BpzCAT or SM50zCAT samples
are normalized to the larger fraction of stained embryos
recorded for GBA–SM50zCAT in Table 1, the levels of expres-
sion achieved by the latter turns out to be about the same as
the normalized control construct values. It follows that there
is no inhibitory effect of any of the components interacting
with GBA on the SM50 regulatory system and vice versa. In
fact, CAT assays show that the total amount of CAT enzyme
produced in embryos expressing GBA–SM50zCAT is approxi-
mately one-third higher than the sum of CAT protein synthe-
sized from SM50zCAT and GBA–BpzCAT separately. This
measurement is shown in Fig. 3 Left.
The experiments summarized in Table 1 show clearly that
theGBA and SM50 regulatory modules function autonomously
when combined in a single construct. Each causes transgene
expression in the appropriate spatial domains of the embryo.
Neither interference effects nor unanticipated expression pat-
terns are observed, and except for a slight enhancement of
overall activity levels, the functions of the Endo16 and SM50
regulatory elements appear strictly additive.
DC Does Not Affect Expression of SM50 Constructs in
Skeletogenic Cells. In the normal context of the Endo16
control system repression of the weak ectopic skeletogenic
expression that would otherwise be caused by the positiveGBA
regulators is accomplished by the DC module. Yuh and
Davidson (5) showed that an interaction with module A is
required in order for module DC to carry out this function.
Since DC precludes Endo16 expression in skeletogenic cells,
we next asked whether this module would also effect the
positive SM50 regulators in the same cells. This would be the
case if DC generates a dominant negative interaction with
components of the transcription apparatus in these cells. Thus
DC was linked to SM50zCAT (DC–SM50zCAT, line 4 of Fig.
1B), and its expression was compared with that of the control
SM50zCAT construct. As illustrated in Fig. 2B, spatial expres-
sion of the SM50zCAT transgene is not affected at all by
addition of DC. There is no apparent decrease in PMC
expression. Thus 68.8% of injected embryos express detectable















SM50zCAT 608 418y190 (68.8) 385 3.6 97.6 5.0
GBA-BpzCAT¶ 413 258y155 (62.5) 248 94.4 9.7 9.3
GBA-SM50zCAT 591 471y120 (79.7) 436 72.2 92.9 8.7
DC-SM50zCAT 206 146y60 (70.9) 142 2.1 98.6 4.9
GDCBA-BpzCAT¶ 636 429y197 (67.5) 422 97.4 2.8 9.8
GBA-DC-BpzCAT 163 126y37 (77.3) 119 96.6 3.4 10.9
GDCBA-SM50zCAT 839 692y147 (82.5) 654 79.5 88.2 11.0
GBA-DC-SM50zCAT 260 200y60 (76.9) 191 89.5 88.5 12.0
7SM50zCAT 226 150y76 (66.4) 141 2.1 100 5.7
GDCBA7SM50zCAT 272 211y61 (77.6) 187 86.6 80.2 10.2
Gastrulae were collected at 48–54 h postfertilization. PMC, primary mesenchyme cell.
*Values represent data from at least four separate experiments carried out on independent batches of eggs.
†Embryos with more than two labeled cells were scored as labeled.
‡Percent expression 5 [¥ labeled embryosy¥ labeled 1 unlabeled embryos] 3 100.
§Percent territorial expression 5 [¥ embryos labeled in given territoryy¥ labeled, interpretable embryos].
¶Exactly comparable data were obtained in ref. 5; see table 2 therein. Specifically, ectopic expression generated byGBA-BpzCAT was 9.4% in PMCs
and 15.0% in ectoderm, while in GDCBA-BpzCAT it was 1.4% in PMCs and 2.6% in ectoderm. Essentially the same data were obtained with the
complete construct—i.e., Endo16zCAT. All of these constructs were expressed in endoderm in $94% of stained embryos, as in the present work.
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SM50zCAT and 70.9% express DC–SM50zCAT (Table 1); the
fraction of embryos scoring positive by whole mount in situ
hybridization is a sensitive measure of the level of expression
(5, 9). On the other hand, when the same batches of embryos
are injected with GDCBA–BpzCAT (line 5 of Fig. 1B) the 10%
ectopic PMC expression observed with GBA–BpzCAT is elim-
inated, reducing skeletogenic expression to background levels
(Table 1). An example of an embryo bearingGDCBA–BpzCAT
and displaying expression exclusively in the gut is shown in Fig.
2C. These data are again in excellent quantitative agreement
with previous observations (6), which for comparison are
reproduced in Table 1, and they confirm that DC is a repressor
of ectopic Endo16 expression in PMCs. Since DC does not
affect expression of the SM50 regulators in theDC–SM50zCAT
construct, while it eliminates all but background expression of
GDCBA–BpzCAT, the repressive effects of this module are
apparently dedicated to the Endo16 regulatory system.
In constructDC–SM50zCATmoduleDC is directly upstream
of the SM50 regulatory sequences. To test whether the position
of DC affects its function, we constructed plasmid GBA–DC–
BpzCAT (line 6 of Fig. 1B), which more closely reflects the
FIG. 3. Quantitative expression of various reporter gene constructs
carrying SM50 and Endo16 regulatory modules at the late gastrula
stage. The number of CAT enzyme molecules per embryo was
determined in CAT assays by comparison of the samples to standards
of known CAT protein concentration. All data are averages, and
vertical lines through the bars represent standard deviations (n 5 4).
The values measured separately for GBA–BpzCAT and SM50zCAT
(Left) or GDCBA–BpzCAT and SM50zCAT (Right) are shown as white
and black bars, respectively. These values were added, and the totals
set to 100%. Experimental values obtained with GBA–SM50zCAT and
GDCBA–SM50zCAT were compared with these totals and also ex-
pressed as percentages (gray bars).
displaying appropriate GDCBA–BpzCAT expression (line 5 of Fig. 1B)
in the gut cells. (D) Embryo showing normal expression of GBA–DC–
BpzCAT (line 6 of Fig. 1B) in a large clone in the archenteron. (E)
Embryo carrying GDCBA–SM50zCAT reporter constructs (line 7 of
Fig. 1B), displaying patches of stained cells in both gut and skeleto-
genic mesenchyme. (F) Embryo expressingGBA–DC–SM50zCAT (line
8 of Fig. 1B) in skeletogenic mesenchyme and archenteron cells. (G)
Embryo carrying reporter genes that contain a large, nonfunctional
spacer element upstream of SM50zCAT (7SM50zCAT, construct 9 of
Fig. 1B) displaying CAT transcripts in PMCs only. (H)
GDCBA7SM50zCAT (line 10 of Fig. 1B) also locates reporter gene
expression to the skeletogenic mesenchyme and gut.
FIG. 2. Spatial expression patterns of various reporter constructs
containing SM50 and Endo16 regulatory modules at the late gastrula
stage. The spatial distribution of CAT transcripts was detected by
whole mount in situ hybridization, using a digoxigenin-labeled anti-
sense CAT RNA probe, and analyzed by means of differential inter-
ference contrast microscopy. The embryos in A and H are shown as
optical sections perpendicular to the animal–vegetal axis. The oral
ectoderm is positioned at the top of each panel, and the PMCs are
external to the circular gut. The embryos in C, E, and F are displayed
in frontal view, with the gut in the center and the PMCs lateral to the
gut. B, D, and G show embryos in lateral view, with the oral side
oriented to the right of the tube-shaped gut and the PMCs in the
blastocoel. Black arrowheads indicate labeled PMCs, and white ar-
rowheads indicate labeled gut cells. (A) Embryo showing normal
SM50zCAT (line 1 of Fig. 1B) expression exclusively in the skeletogenic
mesenchyme. (B) Embryo expressing DC–SM50zCAT (line 4 of Fig.
1B) in a clone of PMCs. The specimen is oriented with the plane of
focus slightly oblique to the gut. Consequently, two of the labeled cells
are superimposed on the contours of the gut. Changing the focal plane
to a plane less useful for displaying the morphological features of the
embryo demonstrates that all labeled cells are PMCs. (C) Embryo
13852 Developmental Biology: Kirchhamer et al. Proc. Natl. Acad. Sci. USA 93 (1996)
arrangement in DC–SM50zCAT with respect to the distance of
DC to the start site compared with GDCBA–BpzCAT. Table 1
shows that GBA–DC–BpzCAT expression in the three embry-
onic territories monitored is indistinguishable from that of
GDCBA–BpzCAT. An embryo expressing GBA–DC–BpzCAT
in gut cells is illustrated in Fig. 2D.
Reporter constructs carrying a combination of GDCBA or
GBA–DC plus SM50 (GDCBA–SM50zCAT and GBA–DC–
SM50zCAT, lines 7 and 8 of Fig. 1B, respectively), also express
the CAT fusion gene in a very high fraction of both skeleto-
genic mesenchyme and gut cells. Representative examples
displaying labeled cells in both these territories are shown in
Fig. 2 E and F. Again, the overall percentage of PMC, and of
gut expression is higher in embryos expressing controls DC–
SM50zCAT or GDCBA–BpzCAT, respectively, than in embryos
expressing GDCBA–SM50zCAT or GBA–DC–SM50zCAT (Ta-
ble 1). However, normalized to the total of scored embryos,
there is no significant quantitative difference between controls
and experimental samples, as above. Furthermore, quantita-
tive measurements of CAT expression show that the sum of
CAT enzyme production from SM50zCAT plus GDCBA–
BpzCAT is about 30% less than that of GDCBA–SM50zCAT
(Fig. 3 Right). In summary, the experiments described in this
paragraph show that the PMC activity of the SM50 regulatory
sequence is quantitatively impervious to repression by module
DC, which eliminates the ectopic expression of Endo16 con-
structs in the same cells.
The Endo16 Regulatory System Functions in Combination
with SM50 Regulators When Separated from Them by a
Spacer. A 900-bp spacer element was introduced between the
GDCBA and the SM50 sequences ofGDCBA–SM50zCAT. This
construct, GDCBA7SM50zCAT, is shown in Fig. 1B, line 10.
The fragment used as a spacer was a pMAL-p2 element
containing sequences of the bacterial maltose-binding protein.
We first demonstrated that the spacer is not in itself function-
al—i.e., that it does not affect PMC expression when linked
to SM50zCAT (construct 7SM50zCAT of Fig. 1B, line 9).
Results are illustrated in Fig. 2G and summarized in Table
1 (compare with SM50zCAT of Table 1). Table 1 shows that
GDCBA7SM50zCAT is expressed exactly as is GDCBA–
SM50zCAT. More than 86% of all embryos scored show gut
expression, and around 80% display PMC staining, as com-
pared with 80% gut, and 88% PMC labeling in embryos
injected with GDCBA–SM50zCAT (Table 1). Fig. 2H displays
an embryo expressing GDCBA7SM50zCAT in gut and PMC
cells. This experiment confirms the autonomous function of
the Endo16 regulatory system, and shows that its independent
interaction with the basal transcription apparatus occurs effi-
ciently over a considerable distance.
DISCUSSION
It seems remarkable that a novel gene regulatory system can
be constructed simply by physically linking cis-regulatory
elements from genes that function in different spatial domains.
An earlier example was described by Levine and colleagues
(12), who produced a synthetic cis-regulatory system by com-
bining the modular stripe 2 element of the Drosophila even-
skipped pair rule gene with an element from the gene rhom-
boid that produces bilateral stripes, generating a bilateral
crossed pattern of expression. Here we describe the expression
of a synthetic sea urchin embryo cis-regulatory system that was
created by combining pieces of the Endo16 and SM50 cis-
regulatory systems, and that faithfully functions in both the gut
and the skeletogenic mesenchyme. In these constructs the
basal promoter utilized is that of the SM50 gene, which
happens to have a TATA-less initiator. However, Makabe et al.
(2) showed that the SM50 cis-regulatory system functions just
as well when the initiator sequence is replaced by a synthetic
TATA box sequence. Active expression driven by the Endo16
regulators when they are linked to SM50zCAT requires that the
positive upstreammodules ofEndo16,G, B, andA, interact just
as efficiently with the SM50 basal transcription apparatus as
with its own TATA box-containing promoter. This is shown by
the results of Fig. 3, which demonstrate that the linked
construct GBA–SM50zCAT has even more activity than the
sum of the activities of Endo16–BpzCAT (which contains the
endogenous Endo16 basal promoter, Bp), plus SM50zCAT. In
spatial terms the combined construct expresses exactly as does
the sum of the individual expression domains imposed by the
separate SM50 and Endo16 regulatory systems. Furthermore,
the Endo16 cis-regulatory modules interact efficiently with the
basal SM50 promoter when placed about a kilobase further
away. Earlier studies on both the SM50 (2) and the Endo16 (5)
regulatory systems showed that both also function when asso-
ciated with SV40 basal promoters. The implication of these
studies together with the present demonstration is clearly that
the basal promoter apparatus is promiscuous; all the specificity
for developmental function lies in the distal cis-regulatory
systems, and each of those tested here has an autonomous
capability of animating the basal promoter apparatus. This is
the reason that it is possible to create synthetic spatial regu-
latory systems by combining upstream regulatory elements
from different genes. To our knowledge, this is the first
observation of this kind for a type 1 embryonic system (13), as
the previous examples are confined to Drosophila (12).
The experiments utilizing the negative DC regulatory mod-
ule of Endo16 show that it does not affect expression driven by
the SM50 regulators in skeletogenic cells, though in these same
cells it reduces expression driven by the GBA regulators of
Endo16 to background levels. DC is therefore not a dominant
silencer of transcription in these cells. With respect to the
Endo16 and SM50 regulatory systems it is likely that DC is
dedicated to Endo16. This observation confirms and extends
the previous finding that the function of DC requires interac-
tion with module A of Endo16 (5). However, we cannot
rigorously exclude the possibility that DC fails to affect ex-
pression driven by the SM50 regulators because of some
particular characteristic of the SM50 basal promoter, or be-
cause the DC repressor may bind too far away from the SM50
activators, although we note that no repressive effect was
observed when DC module was brought into direct apposition
in the construct DC–SM50zCAT.
Repressive elements that control spatial expression by ded-
icated interaction with particular positive regulatory elements
within the cis-regulatory system may be a very general and
essential feature of developmental gene regulation. To con-
sider only some particularly well studied examples from em-
bryonic spatial gene control systems, such locally acting neg-
ative regulators are known for Drosophila, in the eve stripe 2
(14, 15), and stripe 3 (16) modules; in the rhomboid lateral
stripe element (17); and in the Kruppel embryonic expression
element (18); and for the sea urchin, in the middle module of
the CyIIIa cytoskeletal actin gene (9, 19) as well as in the
Endo16 gene (5). These are all examples of local dedicated
interaction of negative regulatory elements with other ele-
ments that function positively, such that if they were not
repressed in given embryonic territories, ectopic spatial ex-
pression would result. This is an important and general feature
of the modular autonomy of cis-regulatory systems. It contrib-
utes to the flexibility with which spatial control elements can
be combined in novel arrangements without abrogating func-
tion. That is, a high complexity of positive–negative interac-
tions is afforded by the diverse arrays of upstream transcription
factors, compared with a system in which expression is medi-
ated only by direct interaction of the various repressors with
the same basal transcription apparatus. In any case, in the
example studied here, the DC skeletogenic repressor of
Endo16 has no dominant silencing activity in the cells in which
it is active.
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Of course the main implication of the experimental assem-
bly of a synthetic regulatory system is that it emphasizes the
likelihood that cis-regulatory recombination has been a major
evolutionary mechanism for the generation of new develop-
mental regulatory systems. This is scarcely a new idea (20). But
it is only recently that it has become possible to demonstrate
experimentally the remarkable lack of constraint in the iden-
tity of compatible elements, in spacing, in functionality, or in
linear arrangement, that is a major characteristic of modular
cis-regulatory organization.
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